Tag Archives: shares

Aurora Cannabis to Buy Rival to Create World's Most Valuable Weed Firm

Aurora Cannabis to Buy Rival to Create World’s Most Valuable Weed Firm

Canada’s No. 2 marijuana producer Aurora Cannabis Inc has agreed to buy smaller rival CanniMed Therapeutics Inc for C$1.1 billion ($852 million) as companies jostle to benefit from the country’s legalization of recreational marijuana use later this year.

Canada's Small Financial Firms Get Buzz From Weed Stocks

Canada’s Small Financial Firms Get Buzz From Weed Stocks

Investors are betting Canada’s smaller financial firms could see a jump in revenues after they helped fund marijuana companies ahead of the country’s planned legalization of the drug this year.

Australia to Permit Medicinal Cannabis Exports in Bid to Capture Lucrative Market

Australia to Permit Medicinal Cannabis Exports in Bid to Capture Market

Australia said on Thursday it planned to become the fourth country in the world to legalise medicinal marijuana exports in a bid to score a piece of the estimated $55 billion global market.

Canadian Regulators Ask CanniMed to Abandon Rights Plan Against Aurora Bid

Canadian Regulators Ask CanniMed to Abandon Rights Plan

Medical marijuana maker CanniMed Therapeutics Inc (CMED.TO) should withdraw a shareholder rights plan adopted to fend off a hostile bid from larger rival Aurora Cannibis Inc ABC.TO, two Canadian regulators have ruled.

Emerald Health Northern Vine Labs

Emerald Health Therapeutics Receives $26.5 Million from Exercise of Warrants and Triggers Acceleration of 721,700 Remaining $2.00 Warrants

VICTORIA, British Columbia, Dec. 21, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (“Emerald” or the “Company”) (TSXV: EMH; OTCQX: EMHTF) has elected to exercise its right to accelerate the exercise of $2.00 common share purchase warrants (“Warrants”) issued by the Company on February 10, 2017.

Aurora Cannabis Opposes CanniMed's Bid for Newstrike Resources

Aurora Cannabis Opposes CanniMed’s Bid for Newstrike Resources

Medical marijuana company Aurora Cannabis Inc said on Monday its acquisition-target CanniMed Therapeutics Inc’s plan to buy smaller rival Newstrike Resources Ltd was a “terrible deal” for CanniMed shareholders.

Canada’s Aurora Cannabis Boosts Stake in Australia-Based Cann Group

Canada’s Aurora Cannabis Boosts Stake in Australia-Based Cann Group

Canada’s Aurora Cannabis Inc (ACB.TO) said on Monday it increased its stake in Australia-based Cann Group Ltd (CAN.AX) to 22.9 percent from 19.9 percent, its latest move to expand in the cannabis industry.

How to Buy Marijuana Stocks Quickly and Easily With This New Fund

How to Buy Marijuana Stocks Quickly and Easily With This New Fund

The first U.S. exchange-traded fund, ETF, to focus on marijuana stocks is launching Dec. 26 — days before California legalizes recreational cannabis use on January 1.

Emerald Health Northern Vine Labs

Emerald Health Therapeutics, Inc. Acquires Shares of Vanc Pharmaceuticals Inc.

VICTORIA, British Columbia, Nov. 29, 2017 /Weed Wire/ — Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX: EMHTF) (“Emerald” or the “Company”) announces that it acquired today 1,666,6667 units (the “Units”) of Vanc Pharmaceuticals Inc. (“Vanc”) of Suite 810 – 789 West Pender Street, Vancouver, British Columbia, V6C 1H2 at a price of $0.15 per Unit pursuant to a private placement offering (the “Transaction”).

Can Any Other Cannabis Stock Measure Up to Canopy Growth Right Now?

Can Any Other Cannabis Stock Measure Up to Canopy Growth?

Shares of Canopy Growth Corp. (TSX:WEED) have climbed a stunning 53.8% month over month as of close on November 1. With all of this in mind, has Canopy established itself as the premier cannabis stock for Canadians?

Series A Financing

Plus Receives $2M Series A for Cannabis-Infused Products The Green Opportunity Leads Round

PALO ALTO, Calif., Oct. 18, 2017 /Weed Wire/ — Plus, the cannabis infused products manufacturer, is pleased to announce the closing of its Series A financing (the “Financing”). The Financing was comprised of $2 Million USD of Series A Preferred Stock (the “Shares”), and was led by The Green Opportunity Funds (TGOF)

Shares of Canada's Aphria Slump as Marijuana Faces Regulatory Risk

Shares of Canada’s Aphria Slump as Marijuana Faces Regulatory Risk

Shares of Canadian marijuana company Aphria Inc sank on Tuesday, after the operator of the Toronto Stock Exchange said cannabis companies with U.S. interests would come under heightened scrutiny and could be delisted.

3 Ways to Avoid Marijuana Stock Investment Scams

3 Ways to Avoid Marijuana Stock Investment Scams

Legal pot sales rose a stunning 34% in 2016 to $6.7 billion across North America, according to Arcview Market Research. But with growth this rapid, there’s bound to be more than a few marijuana stock investments that will be left behind.

Big Weed is on Board With Trudeau’s Marijuana Tax Plan

Big Weed is on Board With Trudeau’s Marijuana Tax Plan

Canada’s biggest medical cannabis producers are seeing their stock prices rise after the federal government announced a plan to levy a one dollar per gram tax on recreational marijuana sales.

Pot Investors: This Mistake Cost a Growth Company 35% of its Stock Price!

Pot Investors: This Mistake Cost a Growth Company 35% of its Stock Price!

Marijuana companies should be careful in overselling how much growth will be achieved or what the prospects will look like for the industry. There is a recent example that cannabis investors would be wise to review, and that’s what happened with Freshii Inc..

Zynerba's Stock on a High as Cannabis-Based Drug Succeeds in Trial

Zynerba’s Stock on a High as Cannabis-Based Drug Succeeds in Trial

Zynerba Pharmaceuticals Inc said on Thursday its cannabis-based gel met the main goal in a mid-stage study of patients with Fragile X syndrome, a genetic disorder that causes learning disabilities in adolescents and children.

Why Canopy Growth Corp. Will Become Great Again in the Eyes of Investors

Why Canopy Growth Corp. Will Become Great Again in the Eyes of Investors

Canopy Growth Corp. (TSX:WEED) was the first cannabis stock to the market and quickly captured the attention of traders and risk-taking growth investors alike. As a result, shares of Canopy skyrocketed 300% in a span of just a few months last year.

The 1 Word in GW Pharmaceuticals' Q3 Update That Disappointed Investors

The 1 Word in GW Pharmaceuticals’ Q3 Update That Disappointed Investors

When GW Pharmaceuticals announced its fiscal third-quarter results on Monday, the company provided plenty of information about its performance during the quarter. However, it wasn’t any of the numbers in the update that caused this decline. Instead, one word caused investors’ disappointment.

Why the Bears Are Wrong About The Scotts Miracle-Gro Stock

Why the Bears Are Wrong About The Scotts Miracle-Gro Stock

In mid-June home lawn and fertilizer care specialist The Scotts Miracle-Gro Company (NYSE:SMG) lowered its full-year fiscal 2017 outlook, citing a more than 10% drop in mass retail sales compared to the year-to-date checkpoint from the previous year. That was caused by challenging weather this spring in core markets across the United States.

Better Know a Marijuana Stock: MedReleaf Corp.

Better Know a Marijuana Stock: MedReleaf Corp.

MedReleaf is one of less than four dozen licensed producers and retailers of medical cannabis products in Canada. The company was founded just four years ago, and it focuses on supplying dried cannabis, cannabis oils, and cannabis oil capsules to qualified medical patients in Canada.

If Warren Buffett Were to Buy 1 Marijuana Stock, it Would Be Aphria Inc.

If Warren Buffett Were to Buy 1 Marijuana Stock, it Would Be Aphria Inc.

Warren Buffett is well known as the most successful investor of all time. Buffett spent his formative years under the tutelage of Benjamin Graham, who is known today as the “father of value investing.” Let’s see whether or not Aphria Inc. can pass Buffett’s mentor’s criteriea test.

Here’s Why Emerging Marijuana Stock Cara Therapeutics Inc. Surged

Here’s Why Emerging Marijuana Stock Cara Therapeutics Inc. Surged

Shares of Cara Therapeutics Inc., a clinical-stage biotech company with a focus on treating pain and pruritus, rocketed higher by as much as 11% during Wednesday’s trading session after providing an update to its phase 3 trial involving kappa opioid receptor agonist CR845.

New York Cannabis Company Valley Agriceuticals Sold for $17 Million

New York Cannabis Company Valley Agriceuticals Sold for $17 Million

Multi-state cannabis company iAnthus Capital Management has now planted its flag in New York with Monday’s announced acquisition of Valley Agriceuticals.

An Opportunity for Excess Profits in the Marijuana Industry

An Opportunity for Excess Profits in the Canadian Marijuana Industry

There is an opportunity for excess profits in the Canadian marijuana industry as the market is now in a position to expand at a very high rate, as Canadians have received confirmation that the potential legalization will become a reality.

Marijuana Insiders Cash In Before Canadian Legalization Report

Marijuana Insiders Cash in Before Canadian Legalization Report

Insiders with two of Canada’s largest marijuana companies are cashing in on the industry’s reefer madness before the country introduces its plans for legalized recreational pot.

The Inside Scoop On Aurora Cannabis Inc

The Inside Scoop on Aurora Cannabis Inc.

While shares have backed off the 52 week highs, Aurora Cannabis is making another run towards the highs as investor enthusiasm increases over recreational marijuana legalization in Canada. Here’s the insider scoop and why we like Aurora Cannabis Inc.


Page 1 of 3123
Top